Thousands of people are dying daily around the world from covid-19. In this context, it is important that the FDA move as quickly as possible to approve Paxlovid, since approving this highly effective drug sooner will save many lives. Recent news about the Omicron variant only makes this more urgent, as it becomes important to approve Paxlovid and scale up distribution before the brunt of a new, Omicron-driven covid wave hits the USA. The pandemic is not standing still; doing your best to protect American citizens means scheduling a meeting on Paxlovid for as soon as possible.
I submitted the following: